{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:08:30Z","timestamp":1790849310393,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T00:00:00Z","timestamp":1144886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T00:00:00Z","timestamp":1144886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1038\/sj.leu.2404213","type":"journal-article","created":{"date-parts":[[2006,4,15]],"date-time":"2006-04-15T07:43:33Z","timestamp":1145087013000},"page":"952-957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Phase 1 study of PTK787\/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome"],"prefix":"10.1038","volume":"20","author":[{"given":"G J","family":"Roboz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"List","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rosamilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M W","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E J","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,13]]},"reference":[{"key":"BF2404213_CR1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1995; 1: 27\u201331.","journal-title":"Nat Med"},{"key":"BF2404213_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1096\/fasebj.8.6.7513289","volume":"8","author":"D Weinstat-Saslow","year":"1994","unstructured":"Weinstat-Saslow D, Steeg PS . Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 1994; 8: 401\u2013407.","journal-title":"FASEB J"},{"key":"BF2404213_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0092-8674(91)90642-C","volume":"64","author":"LA Liotta","year":"1991","unstructured":"Liotta LA, Steep PS, Stetler-Stevenson WG . Cancer metastasis and angiogenesis: an imbalance of negative and positive regulation. Cell 1991; 64: 327\u2013336.","journal-title":"Cell"},{"key":"BF2404213_CR4","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V95.8.2637","volume":"96","author":"T Padro","year":"2000","unstructured":"Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 96: 2637\u20132644.","journal-title":"Blood"},{"key":"BF2404213_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V95.1.309","volume":"95","author":"JW Hussong","year":"2000","unstructured":"Hussong JW, Rodgers GM, Shami PJ . Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309\u2013313.","journal-title":"Blood"},{"key":"BF2404213_CR6","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","volume":"96","author":"A Aguayo","year":"2000","unstructured":"Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240\u20132245.","journal-title":"Blood"},{"key":"BF2404213_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1046\/j.1365-2141.2001.02722.x","volume":"113","author":"ED De Bont","year":"2001","unstructured":"De Bont ED, Rosati S, Jacobs S, Kamps WA, Vellenga E . Increased bone marrow vascularization in patients with acute myeloid leukemia: a possible role for vascular endothelial growth factor. Br J Haematol 2001; 113: 296\u2013304.","journal-title":"Br J Haematol"},{"key":"BF2404213_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000236988","volume":"107","author":"HF Dvorak","year":"1995","unstructured":"Dvorak HF, Detmar M, Clafey KP . Vascular permeability factor (vascular endothelial growth factor) \u2013 an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995; 107: 233\u2013235.","journal-title":"Int Arch Allergy Immunol"},{"key":"BF2404213_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00666035","volume":"36","author":"N Ferrara","year":"1995","unstructured":"Ferrara N . The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995; 36: 127\u2013137.","journal-title":"Breast Cancer Res Treat"},{"key":"BF2404213_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/jnci\/87.3.213","volume":"87","author":"HT Zhang","year":"1995","unstructured":"Zhang HT, Craft P, Scott PAE . Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor in MCF-7 human breast carcinoma cells. J Nat Cancer Inst 1995; 87: 213\u2013219.","journal-title":"J Nat Cancer Inst"},{"key":"BF2404213_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/376062a0","volume":"376","author":"F Shalaby","year":"1995","unstructured":"Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML et al. Failure of blood-island formation and vasculogenesis in FLK-1 deficient mice. Nature 1995; 376: 62\u201366.","journal-title":"Nature"},{"key":"BF2404213_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/380435a0","volume":"380","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435\u2013439.","journal-title":"Nature"},{"key":"BF2404213_CR13","first-page":"728","volume":"59","author":"WT Bellamy","year":"1999","unstructured":"Bellamy WT, Richter L, Frutiger Y, Grogan TM . Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999; 59: 728\u2013733.","journal-title":"Cancer Res"},{"key":"BF2404213_CR14","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/sj.bjc.6693515","volume":"81","author":"G Pruneri","year":"1999","unstructured":"Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF et al. Angiogenesis in myelodysplastic syndromes. Br J Cancer 1999; 81: 1398\u20131401.","journal-title":"Br J Cancer"},{"key":"BF2404213_CR15","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood.V89.6.1870","volume":"89","author":"W Fiedler","year":"1997","unstructured":"Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870\u20131875.","journal-title":"Blood"},{"key":"BF2404213_CR16","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1182\/blood.V97.5.1427","volume":"97","author":"WT Bellamy","year":"2001","unstructured":"Bellamy WT, Richter L, Sirjani D, Roxas C, Glinsmann-Gibson B, Frutiger Y et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001; 97: 1427\u20131434.","journal-title":"Blood"},{"key":"BF2404213_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1172\/JCI8978","volume":"106","author":"S Dias","year":"2000","unstructured":"Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 2000; 106: 511\u2013521.","journal-title":"J Clin Invest"},{"key":"BF2404213_CR18","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1073\/pnas.191117498","volume":"98","author":"S Dias","year":"2001","unstructured":"Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L et al. Inhibition of both paracrine and autocrine VEGF\/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA 2001; 98: 10857\u201310862.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404213_CR19","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1182\/blood.V94.11.3717","volume":"94","author":"A Aguayo","year":"1999","unstructured":"Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999; 94: 3717\u20133721.","journal-title":"Blood"},{"key":"BF2404213_CR20","first-page":"2178","volume":"60","author":"JM Wood","year":"2000","unstructured":"Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J et al. PTK787\/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 2000; 60: 2178\u20132189.","journal-title":"Cancer Res"},{"key":"BF2404213_CR21","first-page":"4015","volume":"92","author":"J Drevs","year":"2002","unstructured":"Drevs J, Muller-Driver R, Wittig C, Fuxius S, Esser N, Hugenschmidt H et al. PTK787\/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res 2002; 92: 4015\u20134122.","journal-title":"Cancer Res"},{"key":"BF2404213_CR22","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1200\/JCO.2003.08.092","volume":"21","author":"B Morgan","year":"2003","unstructured":"Morgan B, Thomas AL, Devs J, Hennig J, Buchert M, Jivan A et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787\/ZK 222584, an inhibitor of the vascular endothelial growth factor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 2003; 21: 3955\u20133964.","journal-title":"J Clin Oncol"},{"key":"BF2404213_CR23","first-page":"3671","volume":"96","author":"BD Cheson","year":"2000","unstructured":"Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD et al. Report of the international working group to standardize response criteria for myelodysplastic syndromes. Blood 2000; 96: 3671\u20133674.","journal-title":"Blood"},{"key":"BF2404213_CR24","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1200\/JCO.2005.09.034","volume":"23","author":"AL Thomas","year":"2005","unstructured":"Thomas AL, Morgan B, Horsfield MA, Higginson A, Kay A, Lee L et al. Phase I study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PTK787\/ZK 222584 administered twice daily in patients with advanced cancer. J Clin Oncol 2005; 23: 4162\u20134171.","journal-title":"J Clin Oncol"},{"key":"BF2404213_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1200\/JCO.2005.10.022","volume":"23","author":"G Gasparini","year":"2005","unstructured":"Gasparini G, Longo R, Fanelli M, Teicher BA . Combination of antiangiogenic therapy with other anticancer therapies: results, challenges and open questions. J Clin Oncol 2005; 23: 1295\u20131311.","journal-title":"J Clin Oncol"},{"key":"BF2404213_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1182\/blood.V98.1.241","volume":"98","author":"RM Mesters","year":"2001","unstructured":"Mesters RM, Padro T, Bieker R, Steins M, Kreuter M, Goner M . Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. Blood 2001; 98: 241\u2013243.","journal-title":"Blood"},{"key":"BF2404213_CR27","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1158\/1078-0432.CCR-03-0627","volume":"10","author":"JE Karp","year":"2004","unstructured":"Karp JE, Gojo I, Pili R, Gocke CD, Greer J, Guo C . Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab. Clin Cancer Res 2004; 10: 3577\u20133585.","journal-title":"Clin Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404213","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:34:02Z","timestamp":1648780442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,13]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6,1]]}},"alternative-id":["BF2404213"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404213","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,13]]},"assertion":[{"value":"15 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}